TABLE 1.
FA profile of study oils and daily supplemented FA dose during the study1
| Daily dose |
||||||
| Study oils |
2-wk run-in period | 8-wk intervention period |
||||
| Run-in oil | Echium oil | Fish oil2 | Run-in oil | Echium oil | Fish oil | |
| g/100 g | g/d | |||||
| Oil | 17 | 17 | 17 | |||
| FAs | ||||||
| ∑SFA | 44 | 11 | 12 | 7.5 | 1.8 | 2.1 |
| ∑MUFA (mainly 18:1n–9) | 39 | 18 | 67 | 6.7 | 3.0 | 12 |
| ∑PUFA | 16 | 70 | 20 | 2.8 | 12 | 3.3 |
| 18:2n–6, LA | 16 | 17 | 5.7 | 2.8 | 2.9 | 0.9 |
| 18:3n–6, GLA | — | 11 | — | — | 1.8 | — |
| 18:3n–3, ALA | 0.2 | 30 | 0.6 | — | 5.0 | 0.1 |
| 18:4n–3, SDA | — | 12 | 1.2 | — | 2.0 [≙0.7 en%] | 0.2 |
| 20:5n–3, EPA | — | — | 11 | — | — | 1.9 [≙0.7 en%] |
| 22:5n–3, DPA | — | — | 0.2 | — | — | — |
| 22:6n–3, DHA | — | — | 1.4 | — | — | 0.2 |
1
Data are means of men and women. — indicates a concentration <0.1 g/100 g or <0.1 g/d. ALA, α-linolenic acid; DPA, docosapentaenoic acid; en%, % of total energy intake; GLA, γ-linolenic acid; LA, linoleic acid; SDA, stearidonic acid.
2
EPA-rich fish oil (EPA/DHA 9:1; fish oil was mixed in olive oil).